State Street Corp Mannkind Corp Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Mannkind Corp stock. As of the latest transaction made, State Street Corp holds 9,597,137 shares of MNKD stock, worth $56.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,597,137

Previous 9,556,799 0.42%

Holding current value

$56.9 Million

Previous $49.9 Million 20.82%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $202,093 - $270,264	40,338 Added 0.42%	9,597,137 $60.3 Million
Q2 2024 Aug 14, 2024	SELL	$4.05 - $5.43 $9.66 Million - $12.9 Million	-2,384,593 Reduced 19.97%	9,556,799 $49.9 Million
Q1 2024 May 15, 2024	SELL	$3.25 - $5.27 $3.25 Million - $5.26 Million	-999,003 Reduced 7.72%	11,941,392 $54.1 Million
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $2.42 Million - $3.11 Million	723,794 Added 5.92%	12,940,395 $47.1 Million
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.45 $12.1 Million - $16.9 Million	-3,096,179 Reduced 20.22%	12,216,601 $50.5 Million
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $9.58 Million - $12.3 Million	-2,574,568 Reduced 14.39%	15,312,780 $62.3 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $2.48 Million - $3.54 Million	628,551 Added 3.64%	17,887,348 $73.3 Million
Q4 2022 Feb 14, 2023	SELL	$3.02 - $5.37 $10.8 Million - $19.2 Million	-3,573,447 Reduced 17.15%	17,258,797 $91 Million
Q3 2022 Nov 15, 2022	BUY	$2.99 - $4.35 $24.9 Million - $36.2 Million	8,331,058 Added 66.64%	20,832,244 $64.4 Million
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $5.88 Million - $10.5 Million	-2,203,047 Reduced 14.98%	12,501,186 $47.6 Million
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $4.34 Million - $7.37 Million	1,655,922 Added 12.69%	14,704,233 $54.1 Million
Q4 2021 Feb 14, 2022	SELL	$4.05 - $5.37 $1.5 Million - $1.99 Million	-369,768 Reduced 2.76%	13,048,311 $57 Million
Q3 2021 Nov 15, 2021	SELL	$3.89 - $5.48 $8.74 Million - $12.3 Million	-2,246,118 Reduced 14.34%	13,418,079 $58.4 Million
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.45 $1.96 Million - $2.97 Million	-544,294 Reduced 3.36%	15,664,197 $85.4 Million
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $23.1 Million - $45.2 Million	7,361,308 Added 83.21%	16,208,491 $63.5 Million
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $9.16 Million - $20.7 Million	5,120,111 Added 137.38%	8,847,183 $27.7 Million
Q3 2020 Nov 10, 2020	SELL	$1.56 - $2.08 $156,541 - $208,721	-100,347 Reduced 2.62%	3,727,072 $7.01 Million
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $393,511 - $925,170	418,629 Added 12.28%	3,827,419 $6.7 Million
Q1 2020 May 11, 2020	BUY	$0.84 - $1.76 $2.86 Million - $6 Million	3,408,790 New	3,408,790 $3.51 Million

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.53B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Mannkind Corp Transaction History